• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

识别肝癌中的凋亡相关亚群和预后模型。

Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma.

机构信息

International Cancer Institute, Peking University Health Science Center, Beijing 100191, China.

Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China.

出版信息

Int J Mol Sci. 2023 Feb 2;24(3):2862. doi: 10.3390/ijms24032862.

DOI:10.3390/ijms24032862
PMID:36769187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9918018/
Abstract

Resistance to anoikis is a key characteristic of many cancer cells, promoting cell survival. However, the mechanism of anoikis in hepatocellular carcinoma (HCC) remains unknown. In this study, we applied differentially expressed overlapping anoikis-related genes to classify The Cancer Genome Atlas (TCGA) samples using an unsupervised cluster algorithm. Then, we employed weighted gene coexpression network analysis (WGCNA) to identify highly correlated genes and constructed a prognostic risk model based on univariate Cox proportional hazards regression. This model was validated using external datasets from the International Cancer Genome Consortium (ICGC) and Gene Expression Omnibus (GEO). Finally, we used a CIBERSORT algorithm to investigate the correlation between risk score and immune infiltration. Our results showed that the TCGA cohorts could be divided into two subgroups, with subgroup A having a lower survival probability. Five genes (, , , and DAP3) were identified as anoikis-related prognostic genes. Moreover, the prognostic risk model effectively predicted overall survival, which was validated using ICGC and GEO datasets. In addition, there was a strong correlation between infiltrating immune cells and prognostic genes and risk score. In conclusion, we identified anoikis-related subgroups and prognostic genes in HCC, which could be significant for understanding the molecular mechanisms and treatment of HCC.

摘要

抗失巢凋亡是许多癌细胞的一个关键特征,促进细胞存活。然而,肝细胞癌(HCC)中失巢凋亡的机制尚不清楚。在这项研究中,我们应用差异表达的重叠失巢凋亡相关基因,使用无监督聚类算法对癌症基因组图谱(TCGA)样本进行分类。然后,我们采用加权基因共表达网络分析(WGCNA)来识别高度相关的基因,并基于单变量 Cox 比例风险回归构建预后风险模型。该模型使用来自国际癌症基因组联盟(ICGC)和基因表达综合数据库(GEO)的外部数据集进行验证。最后,我们使用 CIBERSORT 算法来研究风险评分与免疫浸润之间的相关性。我们的研究结果表明,TCGA 队列可以分为两个亚组,亚组 A 的生存概率较低。鉴定出 5 个与失巢凋亡相关的预后基因(、、、和 DAP3)。此外,预后风险模型能够有效地预测总生存期,在 ICGC 和 GEO 数据集上得到验证。此外,浸润免疫细胞与预后基因和风险评分之间存在很强的相关性。总之,我们鉴定了 HCC 中的失巢凋亡相关亚群和预后基因,这可能对理解 HCC 的分子机制和治疗具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/dd95f1325da2/ijms-24-02862-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/1efbcde06035/ijms-24-02862-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/6db739ed0a04/ijms-24-02862-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/22a0aa7f762b/ijms-24-02862-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/f28875fedfbf/ijms-24-02862-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/e67fe286a64a/ijms-24-02862-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/86bb871994d5/ijms-24-02862-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/9b2355e767a2/ijms-24-02862-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/dd95f1325da2/ijms-24-02862-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/1efbcde06035/ijms-24-02862-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/6db739ed0a04/ijms-24-02862-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/22a0aa7f762b/ijms-24-02862-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/f28875fedfbf/ijms-24-02862-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/e67fe286a64a/ijms-24-02862-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/86bb871994d5/ijms-24-02862-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/9b2355e767a2/ijms-24-02862-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d0/9918018/dd95f1325da2/ijms-24-02862-g008.jpg

相似文献

1
Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma.识别肝癌中的凋亡相关亚群和预后模型。
Int J Mol Sci. 2023 Feb 2;24(3):2862. doi: 10.3390/ijms24032862.
2
Identification of anoikis related subtypes and construction of prognostic model in hepatocellular carcinoma.识别肝细胞癌中的失巢凋亡相关亚型并构建预后模型。
Cell Mol Biol (Noisy-le-grand). 2023 Sep 30;69(9):219-228. doi: 10.14715/cmb/2023.69.9.34.
3
Comprehensive Analysis of the Mechanism of Anoikis in Hepatocellular Carcinoma.全面分析肝癌细胞失巢凋亡的机制
Genet Res (Camb). 2024 Sep 11;2024:8217215. doi: 10.1155/2024/8217215. eCollection 2024.
4
Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma.多组学生存预后相关基因在肝肝细胞癌中的鉴定和验证。
Medicine (Baltimore). 2023 Nov 17;102(46):e36190. doi: 10.1097/MD.0000000000036190.
5
Identification and validation of SLCO4C1 as a biological marker in hepatocellular carcinoma based on anoikis classification features.基于失巢凋亡分类特征鉴定和验证SLCO4C1作为肝细胞癌的生物标志物
Aging (Albany NY). 2024 Jan 15;16(2):1440-1462. doi: 10.18632/aging.205438.
6
Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity.基于失巢凋亡相关基因的肝细胞癌预后模型:免疫景观分析与药物敏感性预测
Front Med (Lausanne). 2023 Jul 12;10:1232814. doi: 10.3389/fmed.2023.1232814. eCollection 2023.
7
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.PDZ 结合激酶高表达与肝癌预后不良和免疫浸润相关。
World J Surg Oncol. 2022 Jan 22;20(1):22. doi: 10.1186/s12957-021-02479-w.
8
Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma.开发一种用于肝细胞癌失巢凋亡的预后模型,并鉴定关键基因。
Sci Rep. 2023 Sep 7;13(1):14723. doi: 10.1038/s41598-023-41139-9.
9
Development of a prognostic signature based on anoikis-related genes in hepatocellular carcinoma with the utilization of LASSO-cox method.基于 LASSO-cox 方法的肝细胞癌中与失巢凋亡相关基因的预后签名的开发。
Medicine (Baltimore). 2023 Jul 21;102(29):e34367. doi: 10.1097/MD.0000000000034367.
10
Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.鉴定和验证一种新型的六基因表达谱用于预测肝细胞癌预后。
Front Immunol. 2021 Dec 1;12:723271. doi: 10.3389/fimmu.2021.723271. eCollection 2021.

引用本文的文献

1
Prognostic implications of autophagy and pyroptosis related genes in oral squamous cell carcinoma: research on bioinformatics and experiments.自噬和焦亡相关基因在口腔鳞状细胞癌中的预后意义:生物信息学与实验研究
Front Oncol. 2025 Aug 29;15:1645670. doi: 10.3389/fonc.2025.1645670. eCollection 2025.
2
Hypoxia-anoikis-related genes in LUAD: machine learning and RNA sequencing analysis of immune infiltration and therapy response.肺腺癌中与缺氧-失巢凋亡相关的基因:免疫浸润和治疗反应的机器学习与RNA测序分析
Am J Cancer Res. 2025 Aug 25;15(8):3762-3780. doi: 10.62347/GQVA7530. eCollection 2025.
3
Newly Established Anoikis-Associated Genes Predict the Prognosis of Hepatocellular Carcinoma.

本文引用的文献

1
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors.全球酒精性肝硬化和 HCC 的流行病学:趋势、预测和危险因素。
Nat Rev Gastroenterol Hepatol. 2023 Jan;20(1):37-49. doi: 10.1038/s41575-022-00688-6. Epub 2022 Oct 18.
2
Identification and Validation of Two Heterogeneous Molecular Subtypes and a Prognosis Predictive Model for Hepatocellular Carcinoma Based on Pyroptosis.基于细胞焦亡的肝细胞癌两种异质分子亚型的鉴定和验证及预后预测模型
Oxid Med Cell Longev. 2022 Aug 28;2022:8346816. doi: 10.1155/2022/8346816. eCollection 2022.
3
Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future.
新建立的失巢凋亡相关基因可预测肝细胞癌的预后。
J Hepatocell Carcinoma. 2025 Sep 3;12:2017-2034. doi: 10.2147/JHC.S533398. eCollection 2025.
4
Identification of anoikis-related genes to develop a risk model and predict the prognosis and tumor microenvironment in rectal adenocarcinoma.鉴定与失巢凋亡相关的基因以建立风险模型并预测直肠腺癌的预后和肿瘤微环境。
Front Genet. 2025 Aug 18;16:1604541. doi: 10.3389/fgene.2025.1604541. eCollection 2025.
5
Identification of anoikis-related genes classification patterns and immune infiltration characterization in chronic rhinosinusitis with nasal polyps based on machine learning.基于机器学习的鼻息肉慢性鼻窦炎中失巢凋亡相关基因分类模式识别及免疫浸润特征分析
Front Mol Biosci. 2025 Aug 15;12:1624300. doi: 10.3389/fmolb.2025.1624300. eCollection 2025.
6
Interpretable machine learning driven biomarker identification and validation for prostate cancer.可解释的机器学习驱动的前列腺癌生物标志物识别与验证
Transl Androl Urol. 2025 Jun 30;14(6):1528-1541. doi: 10.21037/tau-2025-242. Epub 2025 Jun 26.
7
Identification of prognostic biomarkers related to epithelial-mesenchymal transition and anoikis in hepatocellular carcinoma using transcriptomics and single-cell sequencing.利用转录组学和单细胞测序鉴定肝细胞癌中与上皮-间质转化和失巢凋亡相关的预后生物标志物
Front Cell Dev Biol. 2025 Jun 19;13:1600546. doi: 10.3389/fcell.2025.1600546. eCollection 2025.
8
Identification of druggable genetic targets for prostate cancer risk based on mendelian randomization and single-cell RNA sequencing.基于孟德尔随机化和单细胞RNA测序鉴定前列腺癌风险的可药物化遗传靶点
Int Urol Nephrol. 2025 Apr 30. doi: 10.1007/s11255-025-04525-y.
9
The role of hypoxia-senescence co-related molecular subtypes and prognostic characteristics in hepatocellular carcinoma.缺氧-衰老共同相关分子亚型在肝细胞癌中的作用及预后特征
Sci Rep. 2025 Apr 11;15(1):12390. doi: 10.1038/s41598-025-97604-0.
10
Multi-cohort validation based on a novel prognostic signature of anoikis for predicting prognosis and immunotherapy response of esophageal squamous cell carcinoma.基于一种新的失巢凋亡预后特征的多队列验证,用于预测食管鳞状细胞癌的预后和免疫治疗反应。
Front Oncol. 2025 Mar 17;15:1530035. doi: 10.3389/fonc.2025.1530035. eCollection 2025.
弥漫性胶质瘤中的失巢凋亡抗性:未来潜在的治疗靶点。
Front Oncol. 2022 Aug 15;12:976557. doi: 10.3389/fonc.2022.976557. eCollection 2022.
4
Anoikis in cancer: The role of lipid signaling.细胞凋亡抵抗在癌症中的作用:脂信号的角色。
Cell Biol Int. 2022 Nov;46(11):1717-1728. doi: 10.1002/cbin.11896. Epub 2022 Aug 28.
5
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.循环生物标志物在肝细胞癌的诊断和治疗中的应用。
Nat Rev Gastroenterol Hepatol. 2022 Oct;19(10):670-681. doi: 10.1038/s41575-022-00620-y. Epub 2022 Jun 8.
6
Pan-Cancer Analysis, Reveals COVID-19-Related BSG as a Novel Marker for Treatment and Identification of Multiple Human Cancers.泛癌分析揭示与COVID-19相关的BSG作为多种人类癌症治疗和识别的新型标志物。
Front Cell Dev Biol. 2022 May 13;10:876180. doi: 10.3389/fcell.2022.876180. eCollection 2022.
7
TGF-β1/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2/STAT3 and SHP2/Grb2 signaling pathways.TGF-β1/SH2B3 轴通过调节 JAK2/STAT3 和 SHP2/Grb2 信号通路调节肺癌细胞的抗失巢凋亡和 EMT。
Cell Death Dis. 2022 May 19;13(5):472. doi: 10.1038/s41419-022-04890-x.
8
The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosis.《墨西哥肝癌第二共识》. 第一部分: 流行病学和诊断.
Rev Gastroenterol Mex (Engl Ed). 2022 Apr-Jun;87(2):216-234. doi: 10.1016/j.rgmxen.2021.10.009. Epub 2022 Apr 14.
9
Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH).非酒精性脂肪性肝炎(NASH)纤维化进展中的潜在生物标志物。
J Endocrinol Invest. 2022 Jul;45(7):1379-1392. doi: 10.1007/s40618-022-01773-y. Epub 2022 Feb 28.
10
The NEK family of serine/threonine kinases as a biomarker for cancer.丝氨酸/苏氨酸激酶的NEK家族作为癌症的生物标志物。
Clin Exp Med. 2023 Feb;23(1):17-30. doi: 10.1007/s10238-021-00782-0. Epub 2022 Jan 17.